Publications by authors named "Xiling Jiang"

Claim this Profile
U
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs.
Wei Gao, Jiang Liu, Cynthia J Musante, Hao Zhu, Matthew Thompson, Xiling Jiang

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.
Cara A Rabik, Shu Wang, Ritu Chadda, Donna Przepiorka, Jonathon Vallejo, Xiling Jiang

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation.
Ashley C Woods, Kelly J Norsworthy, Moran Choe, Brenda J Gehrke, Haiyan Chen, Xiling Jiang, Jiang Liu

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma.
Changgang Guo, Xiling Jiang, Yinglang Zhang, Guochang Bao

Transl Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma.
Chunhong Li, Jiahua Hu, Xiling Jiang, Haiyin Tan, Yiming Mao

Clin Transl Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota and oral cavity cancer: a two-sample bidirectional Mendelian randomization study.
Zhijuan Sun, Chunying Bai, Dandan Hao, Xiling Jiang, Jianxing Chen

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.
Ashley Woods, Kelly J Norsworthy, Xin Wang, Jonathon Vallejo, Edwin Chiu Yuen Chow, Xiling Jiang

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An MRI-only Three-dimensional Cephalometry Protocol based on the Integrated and Modular Architecture of the Human Head.
Xiling Jiang, Jun Pei, Jianwei Liu, Xu Liao, Fucang Jia

Curr Med Imaging· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior cerebral falx plane in MR images to estimate the craniofacial midline.
Jun Pei, Xu Liao, Lingling Ge, Jianwei Liu, Xiling Jiang

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Systems Pharmacology for Rare Disease Drug Development.
Jane Pf Bai, Jie Wang, Yifei Zhang, Lingshan Wang, Xiling Jiang

J Pharm Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomical network modules of the human central nervous-craniofacial skeleton system.
Gele Qing, Fucang Jia, Jianwei Liu, Xiling Jiang

Front Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double U-Net CycleGAN for 3D MR to CT image synthesis.
Bin Sun, Shuangfu Jia, Xiling Jiang, Fucang Jia

Int J Comput Assist Radiol Surg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Ting Shao, Xiling Jiang, Guochang Bao, Chunsheng Li, Changgang Guo

Dis Markers· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Design and application of moxibustion box].
Xi-Ling Jiang, Xi-Yan Gao

Zhongguo Zhen Jiu· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma.
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, Xiaoping Jiang, Lisa Rodriguez, Xiling Jiang, Jiang Liu

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, Laura L Fernandes, Emily Li, Xiling Jiang, Jianghong Fan

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.
Jennifer J Gao, Christy L Osgood, Yutao Gong, Hui Zhang, Erik W Bloomquist, Xiling Jiang

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy.
Lorraine Pelosof, May Tun Saung, Martha Donoghue, Sandra Casak, Sirisha Mushti, Xiling Jiang, Jiang Liu

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of apical root resorption of maxillary incisors between adolescents and adults after orthodontic treatment].
Ling-Ling Ge, Qian Lyu, Xue Bai, Shao-Hong Wu, Xi-Ling Jiang

Shanghai Kou Qiang Yi Xue· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated bioinformatic analysis identifies COL4A3, COL4A4, and KCNJ1 as key biomarkers in Wilms tumor.
Changgang Guo, Xiling Jiang, Junsheng Guo, Yanlong Wu, Guochang Bao

Int J Clin Exp Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma.
Changgang Guo, Ting Shao, Xiling Jiang, Dadong Wei, Zhanhua Wang

Am J Transl Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a minimal physiologically-based pharmacokinetic/pharmacodynamic model to characterize target cell depletion and cytokine release for T cell-redirecting bispecific agents in humans.
Xiling Jiang, Xi Chen, Pharavee Jaiprasart, Thomas J Carpenter, Rebecca Zhou

Eur J Pharm Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents.
Xiling Jiang, Xi Chen, Thomas J Carpenter, Jun Wang, Rebecca Zhou

MAbs· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Translational Application of a Minimal Physiologically Based Pharmacokinetic Model for a Monoclonal Antibody against Interleukin 23 (IL-23) in IL-23-Induced Psoriasis-Like Mice.
Xi Chen, Xiling Jiang, Rajitha Doddareddy, Brian Geist, Thomas McIntosh

J Pharmacol Exp Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.
Xi-Ling Jiang, Hong-Wu Shen, Donald E Mager, Stephan Schmidt, Ai-Ming Yu

Acta Pharm Sin B· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis